BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22278202)

  • 1. Central venous line dysfunction is an independent predictor of poor survival in children with cancer.
    Athale UH; Siciliano S; Cheng J; Thabane L; Chan AK
    J Pediatr Hematol Oncol; 2012 Apr; 34(3):188-93. PubMed ID: 22278202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer.
    Athale U; Siciliano S; Thabane L; Pai N; Cox S; Lathia A; Khan A; Armstrong A; Chan AK
    Pediatr Blood Cancer; 2008 Dec; 51(6):792-7. PubMed ID: 18798556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do children with central venous line (CVL) dysfunction have increased risk of symptomatic thromboembolism compared to those without CVL-dysfunction, while on cancer therapy?
    Halton J; Nagel K; Brandão LR; Silva M; Gibson P; Chan A; Blyth K; Hicks K; Parmar N; Paddock L; Willing S; Thabane L; Athale U
    BMC Cancer; 2012 Jul; 12():314. PubMed ID: 22835078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboembolism in children with sarcoma.
    Athale U; Cox S; Siciliano S; Chan AK
    Pediatr Blood Cancer; 2007 Aug; 49(2):171-6. PubMed ID: 16991135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant association with location of central venous line placement and risk of venous thrombosis in children.
    Male C; Julian JA; Massicotte P; Gent M; Mitchell L;
    Thromb Haemost; 2005 Sep; 94(3):516-21. PubMed ID: 16268465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and risk factors for venous thromboembolism in critically ill children after trauma.
    Hanson SJ; Punzalan RC; Greenup RA; Liu H; Sato TT; Havens PL
    J Trauma; 2010 Jan; 68(1):52-6. PubMed ID: 20065757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies--a randomized, controlled study.
    Ruud E; Holmstrøm H; De Lange C; Hogstad EM; Wesenberg F
    Acta Paediatr; 2006 Sep; 95(9):1053-9. PubMed ID: 16938749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of venous thromboembolism in children.
    Male C; Kuhle S; Mitchell L
    Semin Thromb Hemost; 2003 Aug; 29(4):377-90. PubMed ID: 14517750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for venous thromboembolism in children.
    Gerotziafas GT
    Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL.
    Ortega JJ; Ribera JM; Oriol A; Bastida P; González ME; Calvo C; Egurbide I; Hernández Rivas JM; Rivas C; Alcalá A; Besalduch J; Maciá J; Gardella S; Carnero M; Lite JM; Casanova F; Martinez M; Fontanillas M; Feliu E; San Miguel JF;
    Haematologica; 2001 Jun; 86(6):586-95. PubMed ID: 11418367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival after relapse in children with solid tumors: a follow-up study from the Italian off-therapy registry.
    Ceschel S; Casotto V; Valsecchi MG; Tamaro P; Jankovic M; Hanau G; Fossati F; Pillon M; Rondelli R; Sandri A; Silvestri D; Haupt R; Cuttini M
    Pediatr Blood Cancer; 2006 Oct; 47(5):560-6. PubMed ID: 16395684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central venous line thrombosis in children and young adults with thalassemia major.
    Finkelstein Y; Yaniv I; Berant M; Zilber R; Garty BZ; Epstein O; Lahav J; Tamary H
    Pediatr Hematol Oncol; 2004; 21(5):375-81. PubMed ID: 15205080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism.
    Parpia S; Julian JA; Thabane L; Lee AY; Rickles FR; Levine MN
    Contemp Clin Trials; 2011 Nov; 32(6):829-33. PubMed ID: 21777700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
    Calaminus G; Bamberg M; Jürgens H; Kortmann RD; Sörensen N; Wiestler OD; Göbel U
    Klin Padiatr; 2004; 216(3):141-9. PubMed ID: 15175958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboembolic complications in pediatric hematologic malignancies.
    Athale UH; Chan AK
    Semin Thromb Hemost; 2007 Jun; 33(4):416-26. PubMed ID: 17525899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of gene expression-based classification for neuroblastoma.
    Oberthuer A; Hero B; Berthold F; Juraeva D; Faldum A; Kahlert Y; Asgharzadeh S; Seeger R; Scaruffi P; Tonini GP; Janoueix-Lerosey I; Delattre O; Schleiermacher G; Vandesompele J; Vermeulen J; Speleman F; Noguera R; Piqueras M; Bénard J; Valent A; Avigad S; Yaniv I; Weber A; Christiansen H; Grundy RG; Schardt K; Schwab M; Eils R; Warnat P; Kaderali L; Simon T; Decarolis B; Theissen J; Westermann F; Brors B; Fischer M
    J Clin Oncol; 2010 Jul; 28(21):3506-15. PubMed ID: 20567016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.
    Aksentijevich I; Jones RJ; Ambinder RF; Garrett-Mayer E; Flinn IW
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):965-72. PubMed ID: 16920563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of cancers associated with venous thromboembolism.
    Sørensen HT; Mellemkjaer L; Olsen JH; Baron JA
    N Engl J Med; 2000 Dec; 343(25):1846-50. PubMed ID: 11117976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.